Evidence map›Paper›PMID 27386948›Full record

ArticleBMC cancer2016

Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer.

Jun Kasuga, Takashi Kawahara, Daiji Takamoto, Sachi Fukui, Takashi Tokita, Tomoyuki Tadenuma, Masaki Narahara, Syusei Fusayasu, Hideyuki Terao, Koji Izumi and 10 more

Abstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Inflammation in Penile Squamous Cell Carcinoma: A Comprehensive Review.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jun KasugaDepartment of Urology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 2360004, Japan.
Takashi KawaharaDepartment of Urology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 2360004, Japan. takashi_tk2001@yahoo.co.jp.ORCID 0000-0002-7049-3379
Daiji TakamotoDepartment of Urology, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
Sachi FukuiDepartment of Urology, Yokohama Minato Red Cross Hospital, Yokohama, Japan.
Takashi TokitaDepartment of Urology, Yokosuka Kyosai Hospital, Yokosuka, Japan.
Tomoyuki TadenumaDepartment of Urology, Kanagawa Cancer Center, Yokohama, Japan.
Masaki NaraharaDepartment of Urology, International Goodwill Hospital, Yokohama, Japan.
Syusei FusayasuDepartment of Urology, Yamato Municipal Hospital, Yamato, Japan.
Hideyuki TeraoDepartment of Urology, Fujisawa City Hospital, Fujisawa, Japan.
Koji IzumiDepartment of Urology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
Hiroki ItoDepartment of Urology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 2360004, Japan.
Yusuke HattoriDepartments of Urology and Renal transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Jun-Ichi TeranishiDepartments of Urology and Renal transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Takeshi SasakiDepartment of Pathology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Kazuhide MakiyamaDepartment of Urology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 2360004, Japan.
Yasuhide MiyoshiDepartments of Urology and Renal transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Masahiro YaoDepartment of Urology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 2360004, Japan.
Yasushi YumuraDepartments of Urology and Renal transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Hiroshi MiyamotoDepartments of Pathology and Urology, Johns Hopkins University School of Medicine, Baltimore, USA.
Hiroji UemuraDepartments of Urology and Renal transplantation, Yokohama City University Medical Center, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe neutrophil-to-lymphocyte ratio (NLR), a simple marker of the systemic inflammatory response, has been demonstrated to correlate with patient outcomes for various solid malignancies. We investigated the utility of the pretreatment NLR as a prognosticator in patients who presented with penile cancer.

methodsA total of 41 patients who underwent complete blood count with differential and subsequent radical penectomy from 1988 to 2014 were analyzed. We assessed the correlation between the NLR and the prognosis of penile cancer.

resultsThe median and mean (± SD) NLRs in 41 penile cancer patients were 3.42 and 5.03 ± 4.99, respectively. Based on the area under receiver operator characteristic curve, the cut-off value of NLR was determined to be 2.82. Patients with a high NLR (≥2.82) showed a significantly poorer cancer-specific survival (p = 0.023) than those with a low NLR.

conclusionsThe pretreatment NLR may function as a biomarker that precisely predicts the prognosis in patients with penile cancer.

Indexed as

AgedAged, 80 and overArea Under CurveCarcinoma, Squamous CellHumansLymphocyte CountMaleMiddle AgedNeoplasm StagingNeutrophilsPenile NeoplasmsPrognosisROC CurveSurvival AnalysisBiomarkerImmunohistochemistryNeutrophil-to-lymphocyte ratioPenile cancer

Identifiers

PMID27386948
PMCPMC4936117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.